In this episode, we break down two major policy developments shaping public health, corporate accountability, and medical freedom in America. First, we examine the bipartisan House vote that removed a controversial pesticide liability shield from the Farm Bill — a move advocates are calling a “major win” for farmers, consumers, and families seeking accountability from chemical manufacturers. We explore what the provision would have done, why opposition grew across party lines, and what this means for future pesticide litigation and agricultural policy.

Then, we turn to the Department of Health and Human Services’ new strategy aimed at reducing overmedicalization through psychiatric medications. We discuss the growing national debate around prescription practices, concerns over long-term psychiatric drug use, and how federal health agencies say they plan to encourage more balanced, evidence-based mental health care moving forward.

From environmental health to mental health reform, this episode unpacks the political, scientific, and ethical questions driving two of the week’s most closely watched health policy stories.

www.georgebatista.com

www.johnhenrysoto.com